Company: ACBM
Filing Date: 2025-07-24
Form Type: 10-K
Source: 0001640334-25-001300
Chunk: 488

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-24
Form: 10-K
Item: Item 9
Chunk 488
---
 performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

/s/ KCCW Accountancy Corp.    We have served as the Company’s auditor since 2025.Diamond Bar, CaliforniaJuly 24, 2025   

 F-2Table of Contents

ACRO BIOMEDICAL CO., LTD.

Balance Sheets

  December 31,  December 31,   2024  2023        ASSETS      Current Assets      Cash $476  $376 Prepaid expenses  -   1,250 Security deposit  4,600   - Total Current Assets  5,076   1,626          Operating lease right of use asset  26,898   52,233 Security deposit  -   4,600 TOTAL ASSETS $31,974  $58,459          LIABILITIES AND STOCKHOLDERS’ DEFICIT                 Current Liabilities        Accounts payable and accrued expenses $154,460  $154,444 Deferred revenue  20,000   20,000 Due to related parties  125,588   88,796 Operating lease liabilities - current  26,898   25,335 Total Current Liabilities 326,946  288,575          Operating lease liabilities - noncurrent  -   26,898 TOTAL LIABILITIES  326,946   315,473          Stockholders’ Deficit        Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding